Literature DB >> 24898847

MRI and ¹⁸F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients?

Laura Evangelista1, Domenico Ruggieri, Luigi Pescarini, Giorgio Saladini.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24898847     DOI： 10.1007/s00259-014-2823-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  28 in total

1.  Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.

Authors:  Claudette E Loo; Marieke E Straver; Sjoerd Rodenhuis; Sara H Muller; Jelle Wesseling; Marie-Jeanne T F D Vrancken Peeters; Kenneth G A Gilhuijs
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 2.  Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review.

Authors:  R Prevos; M L Smidt; V C G Tjan-Heijnen; M van Goethem; R G Beets-Tan; J E Wildberger; M B I Lobbes
Journal:  Eur Radiol       Date:  2012-09-16       Impact factor: 5.315

3.  Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.

Authors:  Ukihide Tateishi; Mototaka Miyake; Tomoaki Nagaoka; Takashi Terauchi; Kazunori Kubota; Takayuki Kinoshita; Hiromitsu Daisaki; Homer A Macapinlac
Journal:  Radiology       Date:  2012-04       Impact factor: 11.105

4.  Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.

Authors:  Y Meng; S Ward; K Cooper; S Harnan; L Wyld
Journal:  Eur J Surg Oncol       Date:  2010-11-27       Impact factor: 4.424

5.  Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.

Authors:  Sonia P Li; N Jane Taylor; Andreas Makris; Mei-Lin W Ah-See; Mark J Beresford; J James Stirling; James A d'Arcy; David J Collins; Anwar R Padhani
Journal:  Radiology       Date:  2010-09-21       Impact factor: 11.105

6.  Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.

Authors:  I C Smith; A E Welch; A W Hutcheon; I D Miller; S Payne; F Chilcott; S Waikar; T Whitaker; A K Ah-See; O Eremin; S D Heys; F J Gilbert; P F Sharp
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

7.  Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.

Authors:  Kenneth E Pengel; Bas B Koolen; Claudette E Loo; Wouter V Vogel; Jelle Wesseling; Esther H Lips; Emiel J Th Rutgers; Renato A Valdés Olmos; Marie Jeanne T F D Vrancken Peeters; Sjoerd Rodenhuis; Kenneth G A Gilhuijs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-29       Impact factor: 9.236

8.  Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.

Authors:  Hyeon-Man Baek; Jeon-Hor Chen; Ke Nie; Hon J Yu; Shadfar Bahri; Rita S Mehta; Orhan Nalcioglu; Min-Ying Su
Journal:  Radiology       Date:  2009-03-10       Impact factor: 11.105

9.  Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

Authors:  David Groheux; Mathieu Hatt; Elif Hindié; Sylvie Giacchetti; Patricia de Cremoux; Jacqueline Lehmann-Che; Antoine Martineau; Michel Marty; Caroline Cuvier; Catherine Cheze-Le Rest; Anne de Roquancourt; Dimitris Visvikis; Marc Espié
Journal:  Cancer       Date:  2013-03-15       Impact factor: 6.860

10.  HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy.

Authors:  Olivier Humbert; Alexandre Cochet; Jean-Marc Riedinger; Alina Berriolo-Riedinger; Laurent Arnould; Bruno Coudert; Isabelle Desmoulins; Michel Toubeau; Inna Dygai-Cochet; Séverine Guiu; Charles Coutant; Pierre Fumoleau; François Brunotte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-20       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.